CASI Pharmaceuticals, Inc.
NASDAQ:CASI
6.01 (USD) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 33.879 | 43.107 | 30.168 | 15.141 | 4.131 | 0 | 0 | 0 | 0.048 | 0.024 | 0 | 0.669 | 1.941 | 3.693 | 5.284 | 7.477 | 7.396 | 6.894 | 5.918 | 0.514 | 1.576 | 1.176 | 1.862 | 3.672 | 5 | 5.2 | 4.8 | 4.4 | 0.72 | 0.09 | 0 | 0 | 0 |
| Cost of Revenue
| 14.895 | 15.827 | 12.557 | 9.508 | 3.935 | 1.671 | 0.118 | 0.066 | 0.006 | 0.007 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.078 | -0.9 | -0.7 | -0.3 | 7.4 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 18.984 | 27.28 | 17.611 | 5.633 | 0.196 | -1.671 | -0.118 | -0.066 | 0.041 | 0.016 | 0 | 0.669 | 1.941 | 3.693 | 5.284 | 7.477 | 7.396 | 6.894 | 5.918 | 0.514 | 1.576 | 1.176 | 1.862 | 4.749 | 5.9 | 5.9 | 5.1 | -3 | 0.72 | 0.09 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.56 | 0.633 | 0.584 | 0.372 | 0.047 | 0 | 0 | 0 | 0.869 | 0.685 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1.294 | 1.18 | 1.135 | 1.063 | -0.682 | 1 | 1 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 8.793 | 15.996 | 14.422 | 11.47 | 9.748 | 8.507 | 7.595 | 4.646 | 4.076 | 2.765 | 2.749 | 2.375 | 3.457 | 4.83 | 7.902 | 20.069 | 23.739 | 21.671 | 17.325 | 10.523 | 14.252 | 31.308 | 52.859 | 41.716 | 35.5 | 15.1 | 9 | 0 | 5.94 | 3.67 | 4.77 | 0.65 | 0 |
| General & Administrative Expenses
| 25.387 | 23.449 | 23.766 | 19.661 | 27.336 | 17.997 | 3.156 | 4.775 | 3.118 | 3.757 | 2.991 | 2.798 | 3.052 | 3.398 | 4.104 | 7.765 | 7.387 | 7.394 | 5.92 | 6.571 | 7.023 | 13.932 | 15.815 | 12.674 | 8 | 5.8 | 4.9 | 3.4 | 2.46 | 1.55 | 1.55 | 0.81 | 0.02 |
| Selling & Marketing Expenses
| 16.45 | 14.326 | 14.705 | 7.815 | 3.103 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 41.837 | 37.775 | 38.471 | 27.476 | 30.439 | 17.997 | 3.156 | 4.775 | 3.118 | 3.757 | 2.991 | 2.798 | 3.052 | 3.398 | 4.104 | 7.765 | 7.387 | 7.394 | 5.92 | 6.571 | 7.023 | 13.932 | 15.815 | 12.674 | 8 | 5.8 | 4.9 | 3.4 | 2.46 | 1.55 | 1.55 | 0.81 | 0.02 |
| Other Expenses
| 0.764 | 0.044 | 0.558 | 0.082 | 0.005 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.078 | 0.9 | 0.7 | 0.3 | 0.2 | 0 | 0 | 0.01 | 0 | 0 |
| Operating Expenses
| 50.63 | 53.771 | 52.893 | 38.946 | 40.187 | 26.504 | 10.751 | 9.421 | 7.194 | 6.522 | 5.74 | 5.173 | 6.509 | 8.228 | 12.006 | 27.834 | 31.126 | 29.065 | 23.246 | 17.094 | 21.275 | 45.241 | 68.674 | 55.467 | 44.4 | 21.6 | 14.2 | 3.6 | 8.4 | 5.22 | 6.33 | 1.46 | 0.02 |
| Operating Income
| -31.646 | -26.491 | -35.282 | -33.313 | -39.991 | -26.504 | -10.751 | 9.421 | 7.152 | 26.187 | 5.74 | 4.504 | -4.568 | -4.535 | 6.722 | 22.357 | 23.73 | 51.652 | 17.327 | 16.58 | 19.7 | 44.064 | 66.812 | 50.718 | -38.5 | 15.7 | -9.1 | 6.6 | -7.69 | -5.13 | -6.33 | -1.46 | -0.02 |
| Operating Income Ratio
| -0.934 | -0.615 | -1.17 | -2.2 | -9.681 | 0 | 0 | 0 | 149.908 | 1,103.7 | 0 | 6.729 | -2.354 | -1.228 | 1.272 | 2.99 | 3.209 | 7.492 | 2.928 | 32.257 | 12.503 | 37.454 | 35.883 | 13.813 | -7.7 | 3.019 | -1.896 | 1.5 | -10.681 | -57 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 5.354 | -10.94 | -0.56 | -14.198 | -5.371 | -1.007 | -0.02 | -0.007 | 0.028 | -19.67 | -11.478 | -19.049 | 0.01 | -3.026 | -0.001 | -1.289 | 2.113 | -27.562 | 1.014 | 3.958 | 0.206 | 5.433 | 23.848 | 2.165 | 1.7 | 2.2 | 2.6 | 1.8 | -0.02 | 0.01 | 0.09 | 0.06 | 0 |
| Income Before Tax
| -26.292 | -37.431 | -35.842 | -47.511 | -45.362 | -27.472 | -10.77 | -9.453 | -7.206 | -26.202 | -5.738 | -14.545 | -4.558 | -8.101 | -8.216 | -23.862 | -12.622 | -12.622 | -16.313 | -12.622 | -19.494 | -39.022 | 90.66 | 52.882 | -36.8 | 17.9 | -6.5 | 8.4 | -7.71 | -5.12 | -6.24 | -1.4 | -0.02 |
| Income Before Tax Ratio
| -0.776 | -0.868 | -1.188 | -3.138 | -10.981 | 0 | 0 | 0 | -151.04 | -1,104.325 | 0 | -21.732 | -2.349 | -2.194 | -1.555 | -3.191 | -1.707 | -1.831 | -2.757 | -24.556 | -12.373 | -33.168 | 48.691 | 14.402 | -7.36 | 3.442 | -1.354 | 1.909 | -10.708 | -56.889 | 0 | 0 | 0 |
| Income Tax Expense
| -0.081 | 1.98 | 1.93 | 15.056 | 6.046 | -0.959 | 0.015 | 0.034 | 0.082 | 0.028 | -11.48 | -9.008 | -0.01 | 3.566 | 1.495 | 3.505 | -0.54 | 28.188 | -1.014 | -3.958 | -0.206 | -5.042 | -23.503 | -1.923 | -1.6 | -2.2 | -2.6 | -1.8 | -0.04 | 0.03 | 0.18 | 0 | 0 |
| Net Income
| -26.938 | -39.411 | -37.772 | -62.567 | -51.408 | -27.472 | -10.77 | -9.453 | -7.206 | -26.202 | -5.738 | -14.545 | -4.558 | -8.101 | -8.216 | -23.862 | -22.411 | -49.889 | -16.313 | -12.622 | -19.494 | -39.022 | -43.309 | -48.794 | -36.9 | -13.5 | -6.5 | -4.8 | -7.71 | -5.12 | -6.24 | -1.4 | -0.02 |
| Net Income Ratio
| -0.795 | -0.914 | -1.252 | -4.132 | -12.444 | 0 | 0 | 0 | -151.04 | -1,104.325 | 0 | -21.732 | -2.349 | -2.194 | -1.555 | -3.191 | -3.03 | -7.236 | -2.757 | -24.556 | -12.373 | -33.168 | -23.26 | -13.289 | -7.38 | -2.596 | -1.354 | -1.091 | -10.708 | -56.889 | 0 | 0 | 0 |
| EPS
| -2.02 | -2.89 | -2.78 | -5.66 | -5.36 | -3.24 | -1.75 | -1.69 | -2.22 | -9.16 | -2.2 | -7.63 | -3.87 | -8.37 | -10.3 | -30.35 | -29.29 | -76.35 | -37.25 | -37.35 | -71.61 | -196.07 | -263.3 | -334.27 | -294.11 | -117.1 | -59.4 | -53.9 | -15.42 | -11.91 | -7.43 | -1.67 | -0.024 |
| EPS Diluted
| -2.02 | -2.89 | -2.78 | -5.66 | -5.36 | -3.24 | -1.75 | -1.69 | -2.22 | -9.16 | -2.2 | -7.63 | -3.87 | -8.37 | -10.3 | -30.35 | -29.29 | -76.35 | -37.25 | -37.35 | -71.61 | -196.07 | -263.3 | -334.27 | -294.11 | -117.1 | -59.4 | -53.9 | -15.42 | -11.91 | -7.43 | -1.67 | -0.024 |
| EBITDA
| -27.905 | -7.633 | -32.028 | -16.208 | -31.4 | -24.785 | -10.618 | -9.346 | -7.083 | -6.456 | -5.723 | -4.484 | -4.539 | -1.438 | -6.625 | -18.748 | -25.843 | 5.391 | -18.187 | -19.764 | -18.974 | -47.988 | -89.284 | -51.805 | -39.3 | -17.2 | -11.4 | -8.2 | -7.53 | -4.95 | -6.07 | -1.34 | -0.02 |
| EBITDA Ratio
| -0.824 | -0.177 | -1.062 | -1.07 | -7.601 | 0 | 0 | 0 | -148.455 | -272.1 | 0 | -6.699 | -2.339 | -0.389 | -1.254 | -2.507 | -3.494 | 0.782 | -3.073 | -38.452 | -12.043 | -40.789 | -47.952 | -14.109 | -7.86 | -3.308 | -2.375 | -1.864 | -10.458 | -55 | 0 | 0 | 0 |